Keywords: لوپرولید; prostatic neoplasms; testosterone; prostate-specific antigen; leuprolide; mortality; ADT; androgen deprivation therapy; CAD; continuous androgen deprivation; CRPC; castration resistant prostate cancer; CSS; cause specific survival; IAD; intermittent andro
مقالات ISI لوپرولید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لوپرولید; Cytostatic agents; Emerging contaminants; Environmental samples; Liquid chromatography; Gas chromatography; 5-FU; 5-Fluorouracil; ACT-D; actinomycin-D; A-GLU; Aminoglutethimide; APCI; atmospheric pressure chemical ionization; APPI; atmospheric pressure ph
Keywords: لوپرولید; Bone turnover; Estrogen receptor; Free testosterone; GTx-758; Leuprolide; Prostate cancer; Sex hormone-binding globulin
Keywords: لوپرولید; Polymeric micelles; Therapeutic peptide; Leuprolide; Pharmacokinetics; Sustained release
Keywords: لوپرولید; Prostate cancer cells; PC-3 and LNCaP; Mononuclear cells; LHRH agonist; Leuprolide; Bicalutamide; Inflammatory cytokines
Keywords: لوپرولید; Liquid crystal; Hexagonal phase; Leuprolide; Sustained release injection; Pharmacokinetics
Keywords: لوپرولید; Aging; Androgens; Leuprolide; Macaque; Memory; Primate
Keywords: لوپرولید; GnRH agonist; leuprolide; ovarian stimulation; premature LH surge
Final oocyte maturation with two different GnRH agonists in antagonist co-treated cycles at risk of ovarian hyperstimulation syndrome
Keywords: لوپرولید; GnRH agonist trigger; GnRH antagonist; intracytoplasmic sperm injection; leuprolide; triptorelin;
The in vivo transformation and pharmacokinetic properties of a liquid crystalline drug delivery system
Keywords: لوپرولید; Liquid crystal; SAXS; Subcutaneous drug delivery; Sustained-release; Hexagonal mesophase; Leuprolide;
Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation
Keywords: لوپرولید; PLGA; Leuprolide; Microspheres; Release mechanisms; IVIVC;
Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists
Keywords: لوپرولید; Androgen deprivation therapy; Degarelix; Goserelin; Leuprolide; Prostate cancer;
Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation
Keywords: لوپرولید; Leuprolide; GnRH Analog; Testosterone; Doping
GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model
Keywords: لوپرولید; Androgen deprivation therapy; Cardiovascular disease; Degarelix; Leuprolide; Metabolic syndrome; Orchiectomy;
Theranekron for treatment of endometriosis in a rat model compared with medroxyprogesterone acetate and leuprolide acetate
Keywords: لوپرولید; Endometriosis; Rat model; Theranekron; Medroxyprogesterone; Leuprolide
Ovarian Cysts in the Guinea Pig (Cavia porcellus)
Keywords: لوپرولید; Ovarian cyst; Ovary; Rete ovarii; Guinea pig; Rodent; Leuprolide; Deslorelin; Ovariohysterectomy;
The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression
Keywords: لوپرولید; prostatic neoplasms; androgens; leuprolide; flutamide; sexual behaviorADT, androgen deprivation therapy; PSA, prostate specific antigen; QOL, quality of life
Thiolated chitosan nanoparticles for the nasal administration of leuprolide: Bioavailability and pharmacokinetic characterization
Keywords: لوپرولید; Thiolated polymer; Nanoparticles (NPs); Bioavailability; Leuprolide; Nasal delivery;
Evaluation of thermoresponsive properties and biocompatibility of polybenzofulvene aggregates for leuprolide delivery
Keywords: لوپرولید; Polybenzofulvene; Thermoresponsive; Nano-aggregates; Leuprolide;
Thiolated chitosan: Development and in vivo evaluation of an oral delivery system for leuprolide
Keywords: لوپرولید; Thiomers; Chitosan–TGA; Leuprolide; Tight junctions; Oral drug delivery
Research ReportEvaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice
Keywords: لوپرولید; Alzheimer's disease; β-amyloid; Androgen; Leuprolide; Luteinizing hormone; Testosterone;
Ectopic uterine tissue as a chronic pain generator
Keywords: لوپرولید; CGRP; calcitonin gene-related peptide; DAPI; 4â²,6-diamidino-2-phenylindole; DiI; 1,1â²-dioctadecyl-3,3,3â²,3â²-tertamethyllindocarbocyanine perchlorate; DRG; dorsal root ganglion; EGTA; ethylene glycol tetraacetic acid; FITC; fluorescein isothiocyana
Efficacy of a Second Line Luteinizing Hormone-Releasing Hormone Agonist After Advanced Prostate Cancer Biochemical Recurrence
Keywords: لوپرولید; prostate; prostatic neoplasms; prostate-specific antigen; leuprolide; goserelin; ADT; androgen deprivation therapy; CRPC; castrate resistant PC; GA; goserelin acetate; LA; leuprolide acetate; LHRH; luteinizing hormone-releasing hormone; PC; prostate cance
A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer
Keywords: لوپرولید; prostate; prostatic neoplasms; progression-free survival; leuprolide; acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide; ADT; androgen deprivati
A novel sensitive electrochemical DNA biosensor for assaying of anticancer drug leuprolide and its adsorptive stripping voltammetric determination
Keywords: لوپرولید; Biosensor; ds-DNA; Electrochemistry; Guanine; Leuprolide
Introducing Vantas: The First Once-Yearly Luteinising Hormone-Releasing Hormone Agonist
Keywords: لوپرولید; Buserelin; Goserelin; Histrelin; Implant; Leuprolide; Metastatic prostate cancer; Triptorelin; Vantas
Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue
Keywords: لوپرولید; Endometriosis; Levonorgestrel; Cardiovascular diseases; Leuprolide; Risk factors
Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics
Keywords: لوپرولید; Degarelix; GnRH receptor antagonist; GnRH receptor blocker; Leuprolide; Prostate cancer; PSA
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles
Keywords: لوپرولید; Solid lipid nanoparticles; Leuprolide; Hydrophobic ion pairing; O/O emulsion-evaporation method; Solvent diffusion method in an aqueous system
Rapid and sensitive liquid chromatography–tandem mass spectrometry method for the determination of leuprolide in human serum
Keywords: لوپرولید; Liquid chromatography–tandem mass spectrometry; Leuprolide; Pharmacokinetics
A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol
Keywords: لوپرولید; Luteinizing hormone-releasing hormone; Antipsychotics; Conditioned avoidance response; Antide; Leuprolide
Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery
Keywords: لوپرولید; Cell-penetrating peptide; Oligoarginine; Drug delivery; Epithelial permeation; Leuprolide
Increased marble-burying behavior in ethanol-withdrawal state: Modulation by gonadotropin-releasing hormone agonist
Keywords: لوپرولید; Luteinizing hormone-releasing hormone; Obsessive–compulsive disorder; Leuprolide; Alcoholism; Fluoxetine
New Trends in Managing the Prostate Cancer Patient
Keywords: لوپرولید; Eligard®; Hormone therapy; Leuprolide; Luteinising hormone-releasing hormone agonist; Prostate cancer; Testosterone
Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice
Keywords: لوپرولید; Luteinizing hormone-releasing hormone; Corticotrophin-releasing factor; HPA axis; HPG axis; Stress; Anxiety; Depression; Leuprolide; d-Trp-6-LHRH; Castration
Inappropriate sexual behaviors in cognitively impaired older individuals
Keywords: لوپرولید; sexual behaviors; hypersexuality; tricyclic antidepressants; selective serotonin reuptake inhibitors; medroxyprogesterone acetate; cyproterone acetate; estrogens; leuprolide; aged;
Efficacy of levamisole on experimental endometriosis
Keywords: لوپرولید; Endometriosis; Levamisole; Leuprolide; Medroxyprogesterone acetate;
LHRH antagonist attenuates the effect of fluoxetine on marble-burying behavior in mice
Keywords: لوپرولید; Leuprolide; Fluoxetine; Marble-burying behavior
Eligard® 6: Achieving Optimal Testosterone Control with the Convenience of a Twice-a-Year Formulation
Keywords: لوپرولید; Eligard®; Hormone therapy; Leuprolide; Luteinising hormone-releasing hormone agonist; Prostate cancer; Testosterone;
Optimal Testosterone Control and Eligard®
Keywords: لوپرولید; Eligard; Hormone therapy; Leuprolide; Luteinising hormone-releasing hormone agonist; Prostate cancer; Testosterone
A 12-Month Clinical Study of LA-2585 (45.0 MG): A New 6-Month Subcutaneous Delivery System for Leuprolide Acetate for the Treatment of Prostate Cancer
Keywords: لوپرولید; prostate; clinical trials; prostate cancer; leuprolide; prostate-specific antigenCmax, maximum concentration; LA, leuprolide acetate; LH, luteinizing hormone; LHRH, luteinizing hormone-releasing hormone; PK, pharmacokinetic; PSA, prostate specific antigen
Eligard®: Advantages for Optimal Testosterone Control
Keywords: لوپرولید; Hormone therapy; Intermittent; Leuprolide; LHRH agonists; Prostate cancer; Prostate-specific antigen (PSA)
Eligard® 6: A New Form of Treatment for Prostate Cancer
Keywords: لوپرولید; Atrigel; Eligard; Leuprolide; Luteinising hormone-releasing hormone agonist prolonged-release formulation; Prostate cancer
Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: Development, characterization and interaction with leuprolide
Keywords: لوپرولید; Oral; Sleroglucan; O-Palmitoylscleroglucan; Coated-liposomes; Leuprolide
Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer
Keywords: لوپرولید; Health-related quality of life; Prostate cancer; Androgen suppression; Testosterone recovery; Drug therapy; Leuprolide; Flutamide
Effect of a long acting GnRH analogue or placebo on plasma LH/FSH, urethral pressure profiles and clinical signs of urinary incontinence due to Sphincter mechanism incompetence in bitches
Keywords: لوپرولید; Urinary incontinence; GnRH analogues; Urethra pressure profile; Phenylpropanolamine; Leuprolide
Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain
Keywords: لوپرولید; Endometriosis; depot medroxyprogesterone acetate; leuprolide; bone mineral density; hypoestrogenic symptoms
Ovarian luteinized thecoma with sclerosing peritonitis in an adult woman treated with leuprolide and toremifene in complete remission at 5 years
Keywords: لوپرولید; Luteinized thecoma; Leuprolide; Toremifene;
Eligard®: Pharmacokinetics, Effect on Testosterone and PSA Levels and Tolerability
Keywords: لوپرولید; Eligard®; Leuprolide; Pharmacokinetics; PSA level; Testosterone level; Adverse events; Tolerability;
First report on the efficacy of l-alanine-based in situ-forming implants for the long-term parenteral delivery of drugs
Keywords: لوپرولید; Drug delivery; l-alanine organogelators; In situ-forming implant; Organogel; Leuprolide;